Sheeva Talebian
Reproductive Endocrinologist
CCRM New York
- Sharing the role of technology and partnerships in the design & recruitment of studies.
- Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies.
- Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.
- Discover how real-world data, genomics, and AI are revealing new targets and mechanisms in female-specific and reproductive conditions.
- Learn how data integration is shortening timelines from target identification to preclinical validation.
- Sharing insights into novel drug discovery approaches, the use of AI, multi-omics data, and 3D models.
Reproductive Health
Drug Development
Stasa Stankovic
Chief Executive Officer
Ovartix
Mark Eccleston
Chief Executive Officer
ValiRx
- Explore the mechanism of action and preclinical efficacy of a first-in-class oncolytic peptide targeting triple negative breast cancer (TNBC).
- Understand how peptide-based approaches offer new hope for aggressive and treatment-refractory subtypes of breast cancer.
- Learn about the breast cancer therapeutic roadmap and landscape.
Oncology
Drug Development
Mark Eccleston
Chief Executive Officer
ValiRx
Oliver Bates
Chief Executive Officer
Viramal
- Learn how to align clinical development strategies with licensing milestones to accelerate commercialization in women’s health.
- Explore what pharma and late stage investors look for in licensing-ready assets, from early efficacy signals to regulatory preparedness.
- Understand how to navigate clinical, legal, and market access challenges unique to women’s health to build a compelling licensing case.
Drug Development
Oliver Bates
Chief Executive Officer
Viramal